M&A Deal Summary |
|
|---|---|
| Date | 2006-10-20 |
| Target | Mayne Pharma |
| Sector | Healthcare Services |
| Buyer(s) | Hospira |
| Deal Type | Add-on Acquisition |
| Deal Value | 2.0B USD |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 2003 |
| Sector | Life Science |
| Employees | 19,000 |
| Revenue | 4.5B USD (2014) |
Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness(TM). As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. Hospira, Inc. is based in Lake Forest, Illinois.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 8 |
| Sector (Healthcare Services) | 2 of 3 |
| Type (Add-on Acquisition) | 2 of 4 |
| Country (Australia) | 1 of 2 |
| Year (2006) | 1 of 2 |
| Size (of disclosed) | 1 of 5 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2005-08-01 |
Physiometrix
Billerica, Massachusetts, United States Physiometrix, Inc. designs, manufactures and markets non-invasive medical products -- based on novel gel materials, sophisticated signal-processing electronics technologies, and proprietary software -- for use in anesthesia monitoring during surgical procedures and in other medical settings, including the intensive care unit. The company generated approximately $1.9 million in 2004 sales at the wholesale level primarily through a distribution agreement. |
Buy | $23M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2006-10-31 |
BresaGen
Adelaide, Australia BresaGen Ltd. is a biotechnology company that develops protein and peptide therapeutics. |
Buy | $17M |
